MiR-29 controls aging-related phenotypes through regulation of the p53 signaling pathway
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA421320 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR6353801_1.fastq.gz | Fastqsanger.gz | |||
| SRR6353801_2.fastq.gz | Fastqsanger.gz | |||
| SRR6353802_1.fastq.gz | Fastqsanger.gz | |||
| SRR6353802_2.fastq.gz | Fastqsanger.gz | |||
| SRR6353803_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 16 |
Similar Datasets
Project description:We examine the effects of over-expressing miR-29 on phenotypes related to aging
2022-12-06 | GSE107763 | GEO
Project description:Aging is a consequence of complex molecular changes, but the roles for individual microRNAs (miRNAs) in aging remain unclear. One of the few miRNAs that is upregulated during both normal and premature aging is miR-29. We confirmed this finding in our study in both mouse and monkey models. Follow-up analysis of the transcriptomic changes during normal aging revealed that miR-29 is among the top miRNAs predicted to drive the aging-related gene expression changes. We also showed that partial loss of miR-29 extends the lifespan of Zmpste-/- mice, an established model of progeria, which indicates that miR-29 is functionally important in this accelerated aging model. To examine whether miR-29 upregulation alone is sufficient to promote aging-related phenotypes in vivo, we generated mice in which miR-29 can be conditionally overexpressed (miR-29TG). We found that miR-29 overexpression in mice is sufficient to drive aging-related phenotypes including alopecia, kyphosis, osteoporosis and senescence, and leads to early lethality. Transcriptomic analysis of both young miR-29TG and old WT mice revealed shared downregulation of genes enriched in extracellular matrix and fatty acid metabolism, and shared upregulation of genes in pathways linked to inflammation. Together, these results highlight the functional importance of miR-29 in controlling a gene expression program that drives aging-related phenotypes.
2025-10-22 | GSE216398 | GEO
Project description:miR-29 is an important driver of aging-related phenotypes
| PRJNA893541 | ENA
Project description: Not available
| S-EPMC11349983 | biostudies-literature
Project description:The tumor suppressor p53 is a master regulator of cellar stress responses implicated in the aging process. As a tumor suppressor, the antagonistic pleiotropy (AP) theory predicts a beneficial cancer suppression function for p53 early in life that becomes detrimental late in life, for example by promoting accumulation of senescent cells, an inflammatory cell fate driven by tumor suppressors and linked to age-associated disease. Although p53 signaling is generally activated in aging and disease, p53 is also known to suppress some phenotypes of cellular senescence, and the function of p53 in aged tissues, as well as its causal role in aging, is not well-defined. Here we show, contrary to the prediction of AP, that p53 promotes healthy aging in mice by suppressing inflammation and maintaining metabolic function. Multimodal RNA, protein, epigenetic, and spatial profiling at the single-cell level in aged mouse liver confirmed the expected age-dependent increase of immune infiltration, accumulation of senescent cells, and p53 pathway activation. Knockout of p53 in vivo in hepatocytes of aged, but not young, mice further increased inflammation and immune infiltration. Mechanistically, p53 suppressed DNA replication stress and damage, a precursor to inflammatory signaling, in senescent cells and in aged liver. In aged hepatocytes, p53 directly targeted and maintained expression of metabolic genes, and knockout of p53 sensitized aged mice to metabolic stress-induced liver damage. Conversely, pharmacological activation of p53 with a small molecule MDM2 inhibitor in aged mice reversed age-associated suppression of metabolic genes, decreased age-associated inflammation, delayed onset of frailty, (and extended lifespan) of aged mice. These data suggest that in mice, p53 delays phenotypes of aging, and that this function is targetable, potentially for the benefit of healthy aging in humans.
2026-05-01 | GSE315907 | GEO
Project description:The tumor suppressor p53 is a master regulator of cellar stress responses implicated in the aging process. As a tumor suppressor, the antagonistic pleiotropy (AP) theory predicts a beneficial cancer suppression function for p53 early in life that becomes detrimental late in life, for example by promoting accumulation of senescent cells, an inflammatory cell fate driven by tumor suppressors and linked to age-associated disease. Although p53 signaling is generally activated in aging and disease, p53 is also known to suppress some phenotypes of cellular senescence, and the function of p53 in aged tissues, as well as its causal role in aging, is not well-defined. Here we show, contrary to the prediction of AP, that p53 promotes healthy aging in mice by suppressing inflammation and maintaining metabolic function. Multimodal RNA, protein, epigenetic, and spatial profiling at the single-cell level in aged mouse liver confirmed the expected age-dependent increase of immune infiltration, accumulation of senescent cells, and p53 pathway activation. Knockout of p53 in vivo in hepatocytes of aged, but not young, mice further increased inflammation and immune infiltration. Mechanistically, p53 suppressed DNA replication stress and damage, a precursor to inflammatory signaling, in senescent cells and in aged liver. In aged hepatocytes, p53 directly targeted and maintained expression of metabolic genes, and knockout of p53 sensitized aged mice to metabolic stress-induced liver damage. Conversely, pharmacological activation of p53 with a small molecule MDM2 inhibitor in aged mice reversed age-associated suppression of metabolic genes, decreased age-associated inflammation, delayed onset of frailty, (and extended lifespan) of aged mice. These data suggest that in mice, p53 delays phenotypes of aging, and that this function is targetable, potentially for the benefit of healthy aging in humans.
2026-05-01 | GSE314410 | GEO
Project description:The tumor suppressor p53 is a master regulator of cellar stress responses implicated in the aging process. As a tumor suppressor, the antagonistic pleiotropy (AP) theory predicts a beneficial cancer suppression function for p53 early in life that becomes detrimental late in life, for example by promoting accumulation of senescent cells, an inflammatory cell fate driven by tumor suppressors and linked to age-associated disease. Although p53 signaling is generally activated in aging and disease, p53 is also known to suppress some phenotypes of cellular senescence, and the function of p53 in aged tissues, as well as its causal role in aging, is not well-defined. Here we show, contrary to the prediction of AP, that p53 promotes healthy aging in mice by suppressing inflammation and maintaining metabolic function. Multimodal RNA, protein, epigenetic, and spatial profiling at the single-cell level in aged mouse liver confirmed the expected age-dependent increase of immune infiltration, accumulation of senescent cells, and p53 pathway activation. Knockout of p53 in vivo in hepatocytes of aged, but not young, mice further increased inflammation and immune infiltration. Mechanistically, p53 suppressed DNA replication stress and damage, a precursor to inflammatory signaling, in senescent cells and in aged liver. In aged hepatocytes, p53 directly targeted and maintained expression of metabolic genes, and knockout of p53 sensitized aged mice to metabolic stress-induced liver damage. Conversely, pharmacological activation of p53 with a small molecule MDM2 inhibitor in aged mice reversed age-associated suppression of metabolic genes, decreased age-associated inflammation, delayed onset of frailty, (and extended lifespan) of aged mice. These data suggest that in mice, p53 delays phenotypes of aging, and that this function is targetable, potentially for the benefit of healthy aging in humans.
2026-05-01 | GSE314411 | GEO
Project description:p53 maintains healthy aging [P53KO_PTENKO_RNAseq]
| PRJNA1390894 | ENA
Project description:p53 maintains healthy aging [P53KO_HFD_RNAseq]
| PRJNA1390885 | ENA